<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>59</patient-age><report-id>CA-CELGENEUS-028-22393-13013323</report-id><gender>male</gender><reactions><reaction>DEATH</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>ISTODAX</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>10034623</indication><indication>10028483</indication></indications><outcomes><outcome>Death</outcome></outcomes><country>Canada</country><geo/></meta><original><ichicsr lang="en" xmlns="">
  <ichicsrmessageheader lang="en">
    <messagetype>ichicsr</messagetype>
    <messageformatversion>2.1</messageformatversion>
    <messageformatrelease>2.0</messageformatrelease>
    <messagenumb>CEL000000000001289229</messagenumb>
    <messagesenderidentifier>CELGENE</messagesenderidentifier>
    <messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
    <messagedateformat>204</messagedateformat>
    <messagedate>20130125101839</messagedate>
  </ichicsrmessageheader>
  <safetyreport lang="en">
    <safetyreportversion lang="en">0</safetyreportversion>
    <safetyreportid lang="en">CA-CELGENEUS-028-22393-13013323</safetyreportid>
    <primarysourcecountry>CA</primarysourcecountry>
    <occurcountry>CA</occurcountry>
    <transmissiondateformat>102</transmissiondateformat>
    <transmissiondate>2013-01-25</transmissiondate>
    <reporttype>2</reporttype>
    <serious code="1">Yes</serious>
    <seriousnessdeath>1</seriousnessdeath>
    <seriousnessother>2</seriousnessother>
    <receivedateformat>102</receivedateformat>
    <receivedate>2013-01-21</receivedate>
    <receiptdateformat>102</receiptdateformat>
    <receiptdate>2013-01-21</receiptdate>
    <additionaldocument>2</additionaldocument>
    <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
    <companynumb lang="en">CA-CELGENE-028-22393-13013323</companynumb>
    <medicallyconfirm>1</medicallyconfirm>
    <linkedreport>
      <linkreportnumb>CA-CELGENE-028-21880-10071167</linkreportnumb>
    </linkedreport>
    <linkedreport>
      <linkreportnumb>CA-CELGENE-028-21880-12100557</linkreportnumb>
    </linkedreport>
    <primarysource>
      <reportertitle>Dr</reportertitle>
      <reportergivename>Vishal</reportergivename>
      <reporterfamilyname>Kukreti</reporterfamilyname>
      <reporterorganization>Princess Margaret Hospital</reporterorganization>
      <reporterstreet>610 Univeristy Ave., 5-227</reporterstreet>
      <reportercity>Toronto</reportercity>
      <reporterstate>ON</reporterstate>
      <reporterpostcode>M5G 2M9</reporterpostcode>
      <reportercountry>CA</reportercountry>
      <qualification code="1">Physician</qualification>
      <studyname lang="en">EVCT-999999-25#Istodax Special Access Program in Canada</studyname>
      <sponsorstudynumb>RM-SAP-CAN-001</sponsorstudynumb>
      <observestudytype>2</observestudytype>
    </primarysource>
    <sender>
      <sendertype>1</sendertype>
      <senderorganization>CELGENEUS</senderorganization>
      <senderdepartment>Global Drug Safety</senderdepartment>
      <sendertitle>Manager</sendertitle>
      <sendergivename>Vivian</sendergivename>
      <senderfamilyname>Fonseca</senderfamilyname>
      <senderstreetaddress>300 Connell Drive, Suite 6000</senderstreetaddress>
      <sendercity>Berkeley Heights</sendercity>
      <senderstate>NJ</senderstate>
      <senderpostcode>07922</senderpostcode>
      <sendercountrycode>US</sendercountrycode>
      <sendertel>9082190331</sendertel>
      <senderfax>9086739115</senderfax>
      <senderemailaddress>vfonseca@celgene.com</senderemailaddress>
    </sender>
    <receiver>
      <receivertype>2</receivertype>
      <receiverorganization>FDAPM</receiverorganization>
      <receivergivename>Roger</receivergivename>
      <receivermiddlename>A</receivermiddlename>
      <receiverfamilyname>Goetsch</receiverfamilyname>
      <receivercountrycode>US</receivercountrycode>
    </receiver>
    <patient lang="en">
      <patientinitial>W-Y</patientinitial>
      <patientbirthdateformat>102</patientbirthdateformat>
      <patientbirthdate>19540204</patientbirthdate>
      <patientsex code="1">Male</patientsex>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>10061758</patientepisodename>
        <patientmedicalstartdateformat>610</patientmedicalstartdateformat>
        <patientmedicalstartdate>201108</patientmedicalstartdate>
        <patientmedicalenddateformat>610</patientmedicalenddateformat>
        <patientmedicalenddate>201201</patientmedicalenddate>
      </medicalhistoryepisode>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>10061758</patientepisodename>
        <patientmedicalstartdateformat>610</patientmedicalstartdateformat>
        <patientmedicalstartdate>201203</patientmedicalstartdate>
        <patientmedicalenddateformat>610</patientmedicalenddateformat>
        <patientmedicalenddate>201204</patientmedicalenddate>
      </medicalhistoryepisode>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>10059043</patientepisodename>
        <patientmedicalstartdateformat>610</patientmedicalstartdateformat>
        <patientmedicalstartdate>201205</patientmedicalstartdate>
      </medicalhistoryepisode>
      <medicalhistoryepisode>
        <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
        <patientepisodename>10061819</patientepisodename>
      </medicalhistoryepisode>
      <patientdeath>
        <patientdeathcause>
          <patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
          <patientdeathreport>10063378</patientdeathreport>
        </patientdeathcause>
      </patientdeath>
      <reaction>
        <primarysourcereaction lang="en">DEATH</primarysourcereaction>
        <reactionmeddraversionllt>15.1</reactionmeddraversionllt>
        <reactionmeddrallt>10011906</reactionmeddrallt>
        <reactionmeddraversionpt>15.1</reactionmeddraversionpt>
        <reactionmeddrapt>10011906</reactionmeddrapt>
        <termhighlighted>3</termhighlighted>
        <reactionoutcome code="5">fatal</reactionoutcome>
      </reaction>
      <drug>
        <drugcharacterization code="1">suspsect</drugcharacterization>
        <medicinalproduct>ISTODAX</medicinalproduct>
        <obtaindrugcountry>CA</obtaindrugcountry>
        <drugauthorizationnumb>22,393</drugauthorizationnumb>
        <drugauthorizationcountry>US</drugauthorizationcountry>
        <drugdosageform normalized="unknown">Unknown</drugdosageform>
        <drugadministrationroute code="065">Unknown</drugadministrationroute>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10034623</drugindication>
        <actiondrug code="6">Not Applicable</actiondrug>
        <drugrecurreadministration code="3">Unknown</drugrecurreadministration>
        <activesubstance>
          <activesubstancename>ROMIDEPSIN</activesubstancename>
        </activesubstance>
        <drugreactionrelatedness lang="en">
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>10011906</drugreactionasses>
          <drugassessmentsource lang="en">Reporter</drugassessmentsource>
          <drugresult lang="en">Unknown</drugresult>
        </drugreactionrelatedness>
      </drug>
      <drug>
        <drugcharacterization code="1">suspsect</drugcharacterization>
        <medicinalproduct>ISTODAX</medicinalproduct>
        <obtaindrugcountry>CA</obtaindrugcountry>
        <drugauthorizationcountry>US</drugauthorizationcountry>
        <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
        <drugindication>10028483</drugindication>
        <actiondrug code="6">Not Applicable</actiondrug>
        <drugrecurreadministration code="3">Unknown</drugrecurreadministration>
        <activesubstance>
          <activesubstancename>ISTODAX</activesubstancename>
        </activesubstance>
        <drugreactionrelatedness>
          <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
          <drugreactionasses>10011906</drugreactionasses>
          <drugassessmentsource lang="en">Reporter</drugassessmentsource>
          <drugresult lang="en">Unknown</drugresult>
        </drugreactionrelatedness>
      </drug>
      <summary lang="en">
        <narrativeincludeclinical><Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">DEATH</Semaphore><Semaphore x="2200717" class="Race" value="Marshallese" score="1.00" ID="C43839">RM </Semaphore>SAP <Semaphore x="1671488" class="Procedure" value="Can Enjoy Taste of Food" score="1.00" ID="C111640">CAN </Semaphore>001 (CANADA): <Semaphore x="751292" class="Medicine" value="Istodax" score="0.87" ID="292244">Istodax </Semaphore>Special Access Program in Canada<Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">Initial </Semaphore>information received on 21Jan2013 from a Healthcare <Semaphore x="2425040" class="Occupation" value="Professional Occupation" score="1.00" ID="C75558">Professional </Semaphore>reporting the <Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">death </Semaphore>of a <Semaphore x="1387834" class="Patient Age" value="58" score="1.00" ID=""><Semaphore x="5960701642276865" class="Patient Age" value="58" score="1.00" ID="">58 </Semaphore>year old </Semaphore>male patient who received <Semaphore x="1147572" class="Medicine" value="romiDEPsin" score="0.87" ID="292270">Romidepsin </Semaphore>for the <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>of <Semaphore x="2202647" class="Disease or Finding" value="Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma" score="1.00" ID="C3468">Peripheral Large <Semaphore x="2601349" class="Disease or Finding" value="T-Cell Non-Hodgkin Lymphoma" score="1.00" ID="C3466">T <Semaphore x="2141438" class="Procedure" value="Lymphoma Cell Count" score="1.00" ID="C74613">Cell Lymphoma </Semaphore></Semaphore></Semaphore>(<Semaphore x="2202647" class="Disease or Finding" value="Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma" score="1.00" ID="C3468">PTCL</Semaphore>) and <Semaphore x="2249920" class="Disease or Finding" value="Mycosis Fungoides" score="1.00" ID="C3246">Mycosis Fungoides </Semaphore><Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed </Semaphore>in Jun2011. <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">Therapy </Semaphore>dates, dosages and frequency for <Semaphore x="1147572" class="Medicine" value="romiDEPsin" score="0.87" ID="292270">Romidepsin </Semaphore>were unknown. Lot number and expiration date were not provided. The patient was reported to be on the <Semaphore x="751292" class="Medicine" value="Istodax" score="0.87" ID="292244">Istodax </Semaphore>Special Access Program in Canada. The proposed <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>plan was for the patient to receive <Semaphore x="1147572" class="Medicine" value="romiDEPsin" score="0.87" ID="292270">Romidepsin </Semaphore>14mg/m2 on days 1, 8, 15 of a 28 day cycle times 12 cycles, however it is unknown if that was the dosage the patient actually received (to be confirmed). Relevant medical history included CHOP <Semaphore x="1760803" class="Procedure" value="Chemotherapy" score="1.00" ID="C15632">chemotherapy </Semaphore>(/Aug/2011 - /Jan/2012),GDP <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">therapy </Semaphore>(/Mar/2012 - /Apr/2012), autologous <Semaphore x="3261704" class="MedDRA LLT" value="Stem cell transplant" score="1.00" ID="10063581">stem cell <Semaphore x="1992543" class="AnatomicStructure" value="Graft" score="1.00" ID="C12981">transplant </Semaphore></Semaphore>(/May/2012). In Aug2012, patient <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed </Semaphore>with <Semaphore x="2452036" class="Disease or Finding" value="Recurrent Disease" score="1.00" ID="C38155">relapsed disease</Semaphore>.It was reported that the patient died on an unknown date. The <Semaphore x="1728496" class="Disease or Finding" value="Cause of Death" score="1.00" ID="C81239">cause of <Semaphore x="2895537" class="MedDRA LLT" value="Death" score="1.00" ID="10011906">death </Semaphore></Semaphore>was not provided. No further information was provided. The reporter assessed the causal relationship between <Semaphore x="751292" class="Medicine" value="Istodax" score="0.87" ID="292244">Istodax </Semaphore>and the patient's <Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">death </Semaphore>as unknown. Additional information will be requested from the prescriber.</narrativeincludeclinical>
        <sendercomment lang="en">The temporal relationship between therapy and DEATH suggest that a causal relationship is possible, but underlying disease or co morbidities could provide an alternative explanation.</sendercomment>
      </summary>
    </patient>
  </safetyreport>
</ichicsr></original></faers>